I have been compiling info on artificial sweetners for years and there are some that are OK and some that are really bad for you but here is a bit of an overview of he dangers of using different artificial sweeteners to try to drop your calorie intake.

Aspartame

Aspartame, a dipeptide of aspartic acid and a methyl ester of phenylalanine, is approved for use in pharmaceutical products and is being used increasingly in chewable tablet and sugar-free formulations. Labels for both prescription and nonprescription products must include the phenylalanine content. The major consideration in the use of aspartame in children is in patients with autosomal recessive phenylketonuria. Although heterozygotes do not appear to have clinically significant increases in phenylalanine after ingestion of even large amounts (equivalent to 24 12-oz cans of diet beverages), homozygotes with strict dietary restrictions should avoid aspartame. Children without dietary restrictions could safely ingest 10 mg/kg/day. Dietary consumption of aspartame is typically less than 5 mg/kg/day; young children, however, could ingest considerably more. For example, a 2-year-old child weighing 12 kg consumes 17 mg/kg from drinking one 12-oz can of diet soda and one serving of a sweetened product (eg, cereal, pudding, gelatin, or frozen dessert). Read the rest of this entry »

Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.

Tags: absence seizures, affective disorders, albuminuria, allergy, American Herbal Products Association, American Medical Association, artificial chemical, artificial sweetners, aspartame, aspartic acid, bladder cancer, blisters, Brazil, cancer, chemical, dairy by-product, dairy products, depression, diarrhea, diet beverages, Dietary Supplement, dietary supplements, dizziness, eczema, epilepsy, evidence, fda, FDA/National Cancer Institute, food, food additive, Food additives, food processors, food products, headache, headaches, Hypersensitivity, insomnia, Japan, Japanese government, migraine headaches, mitral valve prolapse, nausea, neuropsychiatric disorders, nonprescription products, oliguria, panic attacks, Paraguay, pharmaceutical agents, pharmaceutical products, phenylketonuria, placebos, product, prurigo, pruritus, Saccharin, salty applications, SeaLife SL 200C 35mm Film Camera, seizure disorders, seizures, sodium chloride, Stevia, strabismus, Sucralose, tachycardia, Tagatose, United States, urticaria, vascular headaches, visual hallucinations, wheezing

The promise of a more youthful look was too tempting for 53-year-old Mary Schwallenberg to pass up. So, when the Food and Drug Administration approved a product that temporarily improves the appearance of frown lines between the eyebrows, the Orlando, Fla., resident took a shot at it. And it wasn’t long before she became one of many people clamoring for regular treatments that often include refreshments and friendly conversation, as well as injections.

Botulinum Toxin Type A (Botox Cosmetic) is a protein complex produced by the bacterium Clostridium botulinum, which contains the same toxin that causes food poisoning. When used in a medical setting as an injectable form of sterile, purified botulinum toxin, small doses block the release of a chemical called acetylcholine by nerve cells that signal muscle contraction. By selectively interfering with the underlying muscles’ ability to contract, existing frown lines are smoothed out and, in most cases, are nearly invisible in a week.

Botox injections are the fastest-growing cosmetic procedure in the industry, according to the American Society for Aesthetic Plastic Surgery (ASAPS). In 2001, more than 1.6 million people received injections, an increase of 46 percent over the previous year. More popular than breast enhancement surgery and a potential blockbuster, Botox is regarded by some as the ultimate fountain of youth.

Schwallenberg, a pharmaceutical sales representative who is excited about her next round of injections, says she wants to look her best for her job. “That’s corporate America for you,” she says. “I have a lot of energy and I just wanted to look good.”

Botox was first approved in 1989 to treat two eye muscle disorders–uncontrollable blinking (blepharospasm) and misaligned eyes (strabismus). In 2000, the toxin was approved to treat a neurological movement disorder that causes severe neck and shoulder contractions, known as cervical dystonia. As an unusual side effect of the eye disorder treatment, doctors observed that Botox softened the vertical frown (glabellar) lines between the eyebrows that tend to make people look tired, angry or displeased. But until this improvement was actually demonstrated in clinical studies, Allergan Inc., of Irvine, Calif., was prohibited from making this claim for the product.
Read the rest of this entry »

Tags: Allergan Inc., America, American Society for Aesthetic Plastic Surgery, American Society for Dermatologic Surgery Botox, April, blepharospasm, board-certified plastic surgeon, botox, Botox Cosmetic, botulism, California, cervical dystonia, chemical called acetylcholine, dermatologic medical officer, Ella L. Toombs, energy, eye disorder, FDA's Division of Vaccines and Related Products Applications, FDA's Office of Cosmetics and Colors, Florida, flu syndrome, food and drug administration, headache, injection site, Irvine, Julianne Clifford, Mary Schwallenberg, movement disorder, muscle contraction, muscle disorders, muscle weakness, nausea, Orlando, pain, pharmaceutical sales representative, plastic surgery, poisoning, prescription product, president, qualified physician, respiratory infection, retail venues, scars, Scott A. Greenberg, skin surgery, strabismus, surgery, the eye disorder treatment, United States, vaccines, Winter Park